Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-CSF for diminished ovarian reserve in IVF/ICSI
ChiCTR2200062412Phase 4Not yet recruiting
- Sponsor
- Second Hospital of Lanzhou University
- Start
- Apr 2023
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Diminished Ovarian Reserve (DOR) comparing G-CSF with Control: placebo (normal saline) (2 arms). Primary endpoint: Optimal embryo rate. Planned start Apr 2023; status: not yet recruiting.
02
Drugs
filgrastim
03
Conditions
Diminished Ovarian Reserve (DOR)
Beyond the preview
Go deeper on ChiCTR2200062412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200062412.